We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.68B
AUM Growth
+$211M
Cap. Flow
-$41.5M
Cap. Flow %
-1.13%
Top 10 Hldgs %
18.5%
Holding
337
New
20
Increased
84
Reduced
184
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 23.47%
2 Healthcare 18%
3 Financials 14%
4 Consumer Discretionary 12.52%
5 Industrials 12.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
201
Insmed
INSM
$29.3B
$7.63M 0.21%
361,521
-126
-0% -$2.39K
VICR icon
202
Vicor
VICR
$9.77B
$7.62M 0.21%
141,119
-46
-0% -$2.27K
JRVR icon
203
James River Group Holdings
JRVR
$192M
$7.55M 0.21%
413,633
-17,106
-4% -$341K
HBI
204
DELISTED
Hanesbrands
HBI
$7.55M 0.21%
1,661,905
-68,692
-4% -$314K
HELE icon
205
Helen of Troy
HELE
$683M
$7.51M 0.2%
69,502
-2,875
-4% -$275K
IBTX
206
DELISTED
Independent Bank Group, Inc.
IBTX
$7.51M 0.2%
+217,399
New +$8.07M
KTOS icon
207
Kratos Defense & Security Solutions
KTOS
$11.8B
$7.47M 0.2%
521,106
-88,945
-15% -$1.2M
FBK icon
208
FB Financial Corp
FBK
$3.08B
$7.46M 0.2%
265,853
-10,979
-4% -$313K
OCFC icon
209
OceanFirst Financial
OCFC
$1.85B
$7.45M 0.2%
476,658
-19,720
-4% -$308K
EFSC icon
210
Enterprise Financial Services Corp
EFSC
$2.4B
$7.4M 0.2%
189,153
-7,828
-4% -$324K
ATMU icon
211
Atmus Filtration Technologies
ATMU
$4.07B
$7.39M 0.2%
+336,438
New +$7.05M
SFNC icon
212
Simmons First National
SFNC
$3.44B
$7.34M 0.2%
425,341
-17,567
-4% -$296K
DVAX
213
DELISTED
Dynavax Technologies
DVAX
$7.25M 0.2%
+560,908
New +$6.39M
FLWS icon
214
1-800-Flowers.com
FLWS
$258M
$7.23M 0.2%
927,491
-38,338
-4% -$352K
DOLE icon
215
Dole
DOLE
$1.25B
$7.22M 0.2%
533,837
-81,574
-13% -$1.05M
TMCI icon
216
Treace Medical Concepts
TMCI
$306M
$7.16M 0.19%
280,091
-87
-0% -$2.25K
FBNC icon
217
First Bancorp
FBNC
$2.7B
$7.12M 0.19%
239,314
-9,884
-4% -$313K
PPBI
218
DELISTED
Pacific Premier Bancorp
PPBI
$7.1M 0.19%
343,114
-14,169
-4% -$295K
BANR icon
219
Banner Corp
BANR
$2.47B
$7.08M 0.19%
162,159
-6,701
-4% -$317K
ASB icon
220
Associated Banc-Corp
ASB
$5.99B
$6.94M 0.19%
427,511
-17,670
-4% -$291K
MYGN icon
221
Myriad Genetics
MYGN
$307M
$6.92M 0.19%
+298,389
New +$6.51M
ASTE icon
222
Astec Industries
ASTE
$988M
$6.91M 0.19%
152,088
+20,829
+16% +$859K
RARE icon
223
Ultragenyx Pharmaceutical
RARE
$2.64B
$6.86M 0.19%
148,644
-43
-0% -$2K
PRVA icon
224
Privia Health
PRVA
$2.83B
$6.64M 0.18%
254,266
+68
+0% +$1.8K
OPLN
225
Openlane
OPLN
$4.59B
$6.58M 0.18%
432,513
-204
-0% -$2.97K

Similar funds

Peregrine Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Peregrine Capital Management held 337 positions worth $3.68B, up 6.1% from $3.47B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Peregrine Capital Management's Q2 2023 filing shows 20 new, 84 increased, 184 reduced and 17 closed positions. Its largest new stake was MYR Group: 79,706 shares worth $11M. The largest sale was AMN Healthcare, an estimated $13.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q2 2023 buy was MYR Group: 79,706 shares worth $11M.
  • Peregrine Capital Management added most to Columbia Banking Systems in Q2 2023, an estimated $9.42M increase.
  • Peregrine Capital Management's biggest Q2 2023 reduction was AMN Healthcare, cutting an estimated $13.2M.
  • Peregrine Capital Management fully exited PHYSICIANS REALTY TRUST in Q2 2023, selling an estimated $10.3M.
  • Peregrine Capital Management's ten largest holdings make up 18% of its $3.68B portfolio in Q2 2023.
  • Peregrine Capital Management opened 20 new positions and closed 17 in Q2 2023.
  • Peregrine Capital Management's portfolio value rose 6.1% quarter-over-quarter to $3.68B.

Based on Peregrine Capital Management's 13F filing for Q2 2023, filed 26 Jul 2023.